Articles related to Hematology/Oncology
Classical Hematology 2023
Gain actionable insights into the diagnosis and management of nonmalignant blood disorders at Mayo Clinic’s Classical Hematology 2023 conference. Elevate your practice with evidence-based strategies from leading experts.
Clinical Pharmacology September 19th 2023
Maternal Hemoglobin Levels in Pregnancy Impact Outcomes for Mother and Child
New research indicates that maternal hemoglobin levels can significantly impact both maternal and neonatal health outcomes, suggesting a need for revised antenatal care guidelines.
Hematology September 11th 2023
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
Discover how base editing via CRISPR-guided cytidine deamination could revolutionize CAR T-cell therapy for T-cell cancers, offering a promising approach to treating relapsed or refractory cases in pediatric patients.
Hematology/Oncology September 11th 2023
Elranatamab, Now Elrexfio, Approved for Hard-to-treat Myeloma
Discover how Elrexfio’s conditional FDA approval could redefine the treatment landscape for patients with difficult-to-treat multiple myeloma. Dive into the promising clinical trial results and understand its potential impact on your practice.
Hematology/Oncology September 5th 2023
Use of Electronic Health Record Data Helps Predict Survival Following Disease-Modifying Therapy in SCA
This study provides new insights into using electronic health records as an efficient tool for predicting survival outcomes in SCA treatment, highlighting the significant role of hydroxyurea in lowering mortality rates.
Hematology September 5th 2023